These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 37795621
1. A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine. Kaya A, Ceylan AF, Kavutcu M, Santamaria A, Šoltésová Prnová M, Stefek M, Karasu Ç. Drug Chem Toxicol; 2024 Sep; 47(5):710-720. PubMed ID: 37795621 [Abstract] [Full Text] [Related]
2. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine. Elmazoglu Z, Prnova MS, Stefek M, Ceylan AF, Aschner M, Rangel-López E, Santamaria A, Karasu C. Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301 [Abstract] [Full Text] [Related]
3. Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity. Reihanifar T, Şahin M, Stefek M, Ceylan AF, Karasu Ç, Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Cell Biochem Funct; 2023 Aug; 41(6):622-632. PubMed ID: 37272424 [Abstract] [Full Text] [Related]
4. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats. Soltesova Prnova M, Ballekova J, Gajdosikova A, Gajdosik A, Stefek M. Physiol Res; 2015 Aug; 64(4):587-91. PubMed ID: 26291727 [Abstract] [Full Text] [Related]
5. Effects of antioxidant stobadine on protein carbonylation, advanced oxidation protein products and reductive capacity of liver in streptozotocin-diabetic rats: role of oxidative/nitrosative stress. Cumaoglu A, Cevik C, Rackova L, Ari N, Karasu C. Biofactors; 2007 Aug; 30(3):171-8. PubMed ID: 18525111 [Abstract] [Full Text] [Related]
6. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose. Elmazoglu Z, Prnova MS, Santamaria A, Stefek M, Karasu C. Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867 [Abstract] [Full Text] [Related]
7. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats. Sato D, Kusunoki M, Shinzawa G, Feng Z, Nishina A, Nakamura T. Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532 [Abstract] [Full Text] [Related]
8. Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats. Yang BB, Hong ZW, Zhang Z, Yu W, Song T, Zhu LL, Jiang HS, Chen GT, Chen Y, Dai YT. Int J Impot Res; 2019 Mar; 31(2):97-104. PubMed ID: 30214006 [Abstract] [Full Text] [Related]
9. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, Bali M, Stefek M, Stolc S, Gajdosik A, Karasu C. Neurochem Res; 2003 Jun; 28(6):815-23. PubMed ID: 12718433 [Abstract] [Full Text] [Related]
10. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats. Oya M, Hosokawa M, Tsukada H, Fukuda K, Nakamura H, Tsukiyama K, Nagashima K, Fujimoto S, Yamada Y, Seino Y. Diabetes Res Clin Pract; 2003 Nov; 62(2):69-77. PubMed ID: 14581143 [Abstract] [Full Text] [Related]
11. QM/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy. Choudhary S, Kumar M, Silakari O. Bioorg Chem; 2021 Mar; 108():104556. PubMed ID: 33376013 [Abstract] [Full Text] [Related]
12. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats. Jaiswal S, Mishra S, Torgal SS, Shengule S. Life Sci; 2018 Aug 15; 207():364-371. PubMed ID: 29936149 [Abstract] [Full Text] [Related]
13. Glycoxidative and nitrosative stress in kidney of experimental diabetic rats: effects of the prydoindole antioxidant stobadine. Cumaoglu A, Stefek M, Bauer V, Ari N, Aricioglu A, Karasu C. Neuro Endocrinol Lett; 2010 Aug 15; 31(3):313-8. PubMed ID: 20588243 [Abstract] [Full Text] [Related]
14. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats. Sasaki H, Naka K, Kishi Y, Furuta M, Sanke T, Mukoyama M, Nanjo K. Exp Neurol; 1997 Aug 15; 146(2):466-70. PubMed ID: 9270057 [Abstract] [Full Text] [Related]
15. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Yülek F, Or M, Ozoğul C, Isik AC, Ari N, Stefek M, Bauer V, Karasu C. Arch Med Res; 2007 Jul 15; 38(5):503-11. PubMed ID: 17560455 [Abstract] [Full Text] [Related]